IPSEN, OOO

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: -

Established: 1929-01-01

Employees: 5.7K

Market Cap: $9.8B

Website: https://www.ipsen.com/

Clinical Trials

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Phase 3

Completed

Conditions: Cervical Dystonia

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-12-16

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 382

Registration Number: NCT01261611

Locations: 🇷🇺
Samara Regional Clinical Hospital, Samara, Russian Federation
🇵🇱
Gabinet Lekarski, Lodz, Poland
🇷🇺
Research Medical Complex "Vashe Zdorovie", Kazan, Russian Federation

and more 45 locations

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Triptorelin Pamoate (Pamorelin® LA 11.25 mg)

First Posted Date: 2010-12-09

Last Posted Date: 2019-02-08

Lead Sponsor: Ipsen

Target Recruit Count: 109

Registration Number: NCT01257425

Locations: 🇩🇪
Urologische Klinik, Neunkirchen, Germany
🇩🇪
Praxis für Urologie, Wuppertal, Germany
🇩🇪
Kreiskrankenhaus, Abteilung Urologie, Bad Bergzabern, Germany

and more 1 locations

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Phase 2

Terminated

Conditions: Endometrial Cancer

Interventions: Drug: BN83495

First Posted Date: 2010-12-01

Last Posted Date: 2019-01-14

Lead Sponsor: Ipsen

Target Recruit Count: 6

Registration Number: NCT01251354

Locations: 🇺🇸
Dept of Obstetrics and Gynecology, Medical College of Georgia, Augusta, Georgia, United States
🇨🇦
Dept of Obstetrics and Gynecology, Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada

and more 6 locations

Dysport® Adult Lower Limb Spasticity Follow-on Study

Phase 3

Completed

Conditions: Spasticity Post-Traumatic Brain Injury
Post-stroke Spasticity

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2010-12-01

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 352

Registration Number: NCT01251367

Locations: 🇵🇱
Krakowska Akademia Neurologii Sp. z o.o., Krakow, Poland
🇸🇰
Derer's Hospital, Bratislava, Slovakia
🇸🇰
Univerzitna nemocnica Bratislava, Bratislava, Slovakia

and more 46 locations

Dysport® Pediatric Lower Limb Spasticity Follow-on Study

Phase 3

Completed

Conditions: Children
Muscle Spasticity
Cerebral Palsy

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2010-12-01

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 216

Registration Number: NCT01251380

Locations: 🇺🇸
The Children's Hospital, Aurora, Colorado, United States
🇺🇸
Gillette Children's Speciality Healthcare, Saint Paul, Minnesota, United States
🇹🇷
Ghulane Military Medical Academy and School of Medicine, Ankara, Turkey

and more 24 locations

Dysport® Adult Lower Limb Spasticity Study

Phase 3

Completed

Conditions: Leg Spasticity

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-11-29

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 388

Registration Number: NCT01249404

Locations: 🇺🇸
The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇺🇸
University of Texas - Houston, Houston, Texas, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

and more 58 locations

Dysport® Pediatric Lower Limb Spasticity Study

Phase 3

Completed

Conditions: Muscle Spasticity
Children
Cerebral Palsy

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-11-29

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 241

Registration Number: NCT01249417

Locations: 🇺🇸
Texas Scottish Rite - Hospital for Children, Dallas, Texas, United States
🇺🇸
Children's Hospital of Michigan, Detroit, Michigan, United States
🇲🇽
Centro de Rehabilitacion Integral de Queretaro (CRIQ), Queretaro, Mexico

and more 26 locations

A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke

Terminated

Conditions: Upper Limb Spasticity After Stroke

First Posted Date: 2010-11-11

Last Posted Date: 2020-03-31

Lead Sponsor: Ipsen

Target Recruit Count: 45

Registration Number: NCT01239628

Locations: 🇧🇪
Heilig Hart Ziekenhuis, Lier, Belgium
🇧🇪
AZ St-Jan, Brugge, Belgium
🇧🇪
AZ Sint Lucas, Gent, Belgium

and more 8 locations

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Completed

Conditions: Neuroendocrine Tumors
Carcinoid Syndrome

First Posted Date: 2010-11-04

Last Posted Date: 2020-11-05

Lead Sponsor: Ipsen

Target Recruit Count: 340

Registration Number: NCT01234168

Locations: 🇨🇿
Hospital Pardubice, Pardubice, Czechia
🇫🇷
CHU Angers, Angers, France
🇫🇷
Hôpital Saint André, Bordeaux, France

and more 54 locations

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: BN83495

First Posted Date: 2010-10-29

Last Posted Date: 2019-01-07

Lead Sponsor: Ipsen

Target Recruit Count: 2

Registration Number: NCT01230970

Locations: 🇳🇴
Akershus University Hospital, Lørenskog, Norway

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy